NDC 59651-782 Glipizide
Tablet, Extended Release Oral

Product Information

NDC Product Code59651-782
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		Glipizide
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		Glipizide
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		Glipizide
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		Human Prescription Drug
NDC Directory StatusACTIVE PRODUCT and included in NDC Directory
Dosage FormTablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route(s) What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.
  • Oral - Administration to or by way of the mouth.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		Aurobindo Pharma Limited
Labeler Code59651
SPL SET ID:84794a52-b717-488c-8533-6425c83d405f
FDA Application Number What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.		ANDA206928
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.		ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.		03-03-2023
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.		12-31-2024
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I". 		N
NDC Code Structure

Product Characteristics

Color(s)WHITE (C48325 - WHITE TO OFF-WHITE)
ShapeROUND (C48348)
Size(s)6 MM
Imprint(s)G;2;5
G;5
G;10
Score1

Product Packages

NDC Code 59651-782-01

Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE

NDC Code 59651-782-05

Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE

NDC Code 59651-782-30

Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE

NDC Code 59651-782-99

Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE

Product Details

What is NDC 59651-782?

The NDC code 59651-782 is assigned by the FDA to the product Glipizide which is a human prescription drug product labeled by Aurobindo Pharma Limited. The product's dosage form is tablet, extended release and is administered via oral form. The product is distributed in 4 packages with assigned NDC codes 59651-782-01 100 tablet, extended release in 1 bottle , 59651-782-05 500 tablet, extended release in 1 bottle , 59651-782-30 30 tablet, extended release in 1 bottle , 59651-782-99 1000 tablet, extended release in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Glipizide?

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

What are Glipizide Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
  • GLIPIZIDE 10 mg/1 - An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Which are Glipizide UNII Codes?

The UNII codes for the active ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Glipizide?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 310489 - glipiZIDE 2.5 MG 24HR Extended Release Oral Tablet
  • RxCUI: 310489 - 24 HR glipizide 2.5 MG Extended Release Oral Tablet
  • RxCUI: 310489 - glipizide ER 2.5 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 310489 - glipizide XL 2.5 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 314006 - glipiZIDE 5 MG 24HR Extended Release Oral Tablet

Which are Glipizide Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes for Glipizide?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Product Label

We have moved the product label and warning information to a dedicated page, please follow the link below:

View Product Label